Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20250101 - 20251231
No. 1001 - 1100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1001 | 24973227 |
US |
65 | 2 |
Pain, General physical health deterioration, |
||||
ABATACEPT, |
||||
| 1002 | 24973290 |
TR |
||
General physical health deterioration, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 1003 | 24973350 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1004 | 24973420 |
GR |
88 | 1 |
General physical health deterioration, Oxygen saturation decreased, Bacteraemia, Influenza, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVETIRACETAM, SITAGLIPTIN, ROTIGOTINE, METOPROLOL TARTRATE, METOPROLOL, ATORVASTATIN CALCIUM, |
||||
| 1005 | 24972396 |
US |
||
Neoplasm malignant, Pulmonary fibrosis, Regurgitation, Gastrooesophageal reflux disease, Cough, Hypoacusis, General physical health deterioration, Malaise, Fatigue, Systemic scleroderma, Gastrointestinal disorder, Product use issue, |
||||
ESOMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, |
||||
| 1006 | 24967346 |
FR |
85 | 1 |
Influenza, General physical health deterioration, |
||||
| 1007 | 24967614 |
CA |
||
General physical health deterioration, Diarrhoea, Dyspepsia, Pneumonia, Sinusitis, Bronchitis, Product dose omission issue, Off label use, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, |
||||
| 1008 | 24967786 |
CA |
54 | 1 |
Rhabdomyolysis, Muscle atrophy, General physical health deterioration, Muscular weakness, |
||||
ROSUVASTATIN, EZETIMIBE, AMLODIPINE, BUDESONIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1009 | 24967930 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1010 | 24967939 |
CA |
63 | 2 |
Discomfort, Anxiety, Asthma, Bronchitis, Chest discomfort, Cough, Cystitis escherichia, Diarrhoea, Dyspnoea, Fear, General physical health deterioration, Incorrect dose administered, Ligament rupture, Malaise, Mobility decreased, Pneumonia, Sleep disorder, Throat cancer, Throat clearing, Weight decreased, Weight increased, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, COBIMETINIB, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
| 1011 | 24967943 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1012 | 24967967 |
US |
56 | 2 |
Death, Hospitalisation, General physical health deterioration, |
||||
| 1013 | 24967978 |
US |
||
General physical health deterioration, |
||||
OSIMERTINIB, |
||||
| 1014 | 24968122 |
CA |
59 | 2 |
Abdominal pain, Arrhythmia, Asthenia, Blood pressure abnormal, Blood pressure decreased, Constipation, Corneal erosion, Cough, Decreased appetite, Drug hypersensitivity, Dysgeusia, Gastroenteritis, Gastrointestinal disorder, General physical health deterioration, Haematochezia, Headache, Hypotension, Influenza, Injection site discomfort, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Migraine, Nasopharyngitis, Nausea, Oropharyngeal pain, Pneumonia, Secretion discharge, Urticaria, Urticaria chronic, Vomiting, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MORPHINE, |
||||
| 1015 | 24968134 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Blood cholesterol increased, Decreased appetite, Diarrhoea, Discomfort, Drug intolerance, Duodenal ulcer perforation, Fatigue, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Infusion related reaction, Injury, Joint swelling, Liver injury, Malaise, Mobility decreased, Musculoskeletal stiffness, Pain, Pemphigus, Pericarditis, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Wound, Adverse event, Adverse drug reaction, Exposure during pregnancy, Maternal exposure during pregnancy, Drug ineffective, Treatment failure, Therapeutic product effect decreased, Intentional product use issue, Product use issue, Contraindicated product administered, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, PREDNISONE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CALCIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ABATACEPT, APREMILAST, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, SULFASALAZINE, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, PREDNISONE, TOFACITINIB, CAFFEINE CITRATE, CAFFEINE CITRATE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, ERGOCALCIFEROL, |
||||
| 1016 | 24968166 |
US |
79 | 2 |
General physical health deterioration, Dyspnoea, Oxygen saturation abnormal, Confusional state, Pain, |
||||
TREPROSTINIL, TREPROSTINIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FLUTICASONE PROPIONATE, ESTRADIOL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, LEVOTHYROXINE SODIUM, OXYGEN, 0XYGEN, DIPHENHYDRAMINE HYDROCHLORIDE, GABAPENTIN, |
||||
| 1017 | 24968261 |
US |
2 | |
Dysphagia, General physical health deterioration, |
||||
| 1018 | 24968416 |
CA |
80 | 1 |
Bone cancer, Weight increased, Muscle spasms, Weight decreased, Anaemia, Vomiting, Nausea, General physical health deterioration, |
||||
MORPHINE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 1019 | 24968420 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1020 | 24968472 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1021 | 24968473 |
FR |
1 | |
Metastasis, Right ventricular failure, Neutropenia, Thrombocytopenia, Respiratory distress, General physical health deterioration, |
||||
AMIVANTAMAB, AMIVANTAMAB, PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, |
||||
| 1022 | 24968522 |
BE |
79 | 2 |
Panic attack, General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, AMANTADINE, |
||||
| 1023 | 24968627 |
US |
65 | 1 |
General physical health deterioration, Drug ineffective, Dyspnoea, |
||||
CYCLOSPORINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, EVEROLIMUS, EVEROLIMUS TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, |
||||
| 1024 | 24968636 |
CA |
2 | |
Deep vein thrombosis, Dyspnoea, General physical health deterioration, Hypoxia, Myasthenia gravis, Peripheral swelling, Pulmonary embolism, Pulmonary infarction, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 1025 | 24969015 |
CA |
63 | 1 |
Death, Arthritis infective, General physical health deterioration, Osteomyelitis, Product dose omission issue, Sepsis, |
||||
| 1026 | 24969235 |
HR |
89 | 2 |
General physical health deterioration, Intra-abdominal haemorrhage, Hypotension, Somnolence, Sopor, Fall, Bradycardia, |
||||
DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, |
||||
| 1027 | 24969243 |
CA |
68 | 2 |
Vitreous floaters, Abdominal pain, Tenderness, General physical health deterioration, Diarrhoea, Impaired work ability, Social problem, Arthralgia, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 1028 | 24969260 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, Pain, Contraindicated product administered, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREPITANT, HYDROCORTISONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, OXYCODONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, |
||||
| 1029 | 24969425 |
US |
2 | |
General physical health deterioration, Condition aggravated, Intentional dose omission, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1030 | 24969434 |
IN |
70 | 2 |
Cough, Immune system disorder, Haemoglobin decreased, Anaemia, Asthenia, Neoplasm, Off label use, Rash, Blood creatinine increased, Mucosal toxicity, Lung neoplasm, Blood thyroid stimulating hormone increased, Portal vein thrombosis, Haemorrhoids, Post procedural infection, Portal vein thrombosis, Abdominal pain upper, Hepatic cirrhosis, General physical health deterioration, Blood urea increased, Blood creatinine increased, Immune-mediated adverse reaction, Blood thyroid stimulating hormone decreased, Thyroxine free increased, Carcinoembryonic antigen increased, Glomerular filtration rate decreased, Pulmonary mass, Lymphadenopathy, Positron emission tomogram abnormal, Tumour thrombosis, |
||||
ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, |
||||
| 1031 | 24969448 |
SE |
81 | 2 |
General physical health deterioration, Depressed level of consciousness, Tachypnoea, Dysuria, Confusional state, Pyrexia, Anxiety, |
||||
ZOLEDRONIC ACID, |
||||
| 1032 | 24969587 |
US |
1 | |
Near death experience, Malaise, General physical health deterioration, Product dose omission issue, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, MORPHINE, |
||||
| 1033 | 24969834 |
US |
||
Septic shock, Respiratory distress, Amyotrophic lateral sclerosis, General physical health deterioration, COVID-19, |
||||
EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT), |
||||
| 1034 | 24969975 |
DE |
72 | 2 |
General physical health deterioration, Neoplasm progression, |
||||
LETROZOLE, LETROZOLE TABLETS, PALBOCICLIB, |
||||
| 1035 | 24969986 |
CA |
||
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Alopecia, Amnesia, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear pain, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Grip strength decreased, Hepatic enzyme increased, Impaired healing, Infection, Inflammation, Irritable bowel syndrome, Joint range of motion decreased, Lip dry, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nasopharyngitis, Nausea, Night sweats, Obesity, Osteoarthritis, Paraesthesia, Peripheral swelling, Peripheral venous disease, Pneumonia, Pulmonary fibrosis, Stomatitis, Urticaria, Weight increased, Wound infection, Contraindicated product administered, Exposure during pregnancy, Incorrect route of product administration, Maternal exposure during pregnancy, Intentional product use issue, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CALCIUM CARBONATE, ANTACID, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 1036 | 24970011 |
US |
1 | |
Tracheostomy, General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1037 | 24970341 |
BE |
70 | 1 |
General physical health deterioration, Diarrhoea, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, PREDNISONE, |
||||
| 1038 | 24970438 |
HR |
89 | 2 |
General physical health deterioration, |
||||
IDARUCIZUMAB, |
||||
| 1039 | 24970614 |
DE |
89 | 2 |
Toxicity to various agents, Pancytopenia, Encephalopathy, Influenza like illness, Nausea, Vomiting, Diarrhoea, General physical health deterioration, Hepatic enzyme increased, Incorrect dosage administered, |
||||
METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, |
||||
| 1040 | 24970619 |
PL |
65 | 2 |
Blood pressure increased, Chest pain, Gastrointestinal disorder, Upper respiratory tract infection, General physical health deterioration, Neurological symptom, |
||||
ENCORAFENIB, BINIMETINIB, |
||||
| 1041 | 24970701 |
CA |
||
Abdominal discomfort, Alopecia, Blister, Depression, Diarrhoea, Drug intolerance, Duodenal ulcer perforation, Fibromyalgia, General physical health deterioration, Glossodynia, Pemphigus, Pericarditis, Rash, Swelling, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Wheezing, Wound, Live birth, Synovitis, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Hand deformity, Joint range of motion decreased, Breast cancer stage III, Helicobacter infection, Wound infection, Intentional product use issue, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 1042 | 24970814 |
US |
||
Weight increased, General physical health deterioration, Dyspepsia, Mental disorder, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 1043 | 24970821 |
US |
78 | 1 |
Arthralgia, General physical health deterioration, |
||||
ABATACEPT, |
||||
| 1044 | 24971237 |
AT |
51 | 2 |
Cardiac failure acute, Proctalgia, Colonic fistula, Cardiomyopathy, Intestinal stenosis, Emphysema, Cardiomegaly, Stoma creation, Crohn^s disease, Colitis ulcerative, Aspiration, Intervertebral discitis, Peritonitis, General physical health deterioration, Osteitis, Malnutrition, Weight decreased, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 1045 | 24971398 |
CA |
40 | 2 |
Synovitis, Taste disorder, Vomiting, Weight increased, Wound, Drug hypersensitivity, Drug intolerance, Product use issue, Product quality issue, Intentional product use issue, Contraindicated product administered, Product use in unapproved indication, Treatment failure, Therapeutic product effect decreased, Therapeutic product effect incomplete, Drug ineffective, Wheezing, Musculoskeletal stiffness, Malaise, Insomnia, Hepatitis, Headache, Gastrointestinal disorder, Finger deformity, Fall, Dyspepsia, Condition aggravated, Coeliac disease, Adverse reaction, Abdominal distension, Grip strength decreased, Product label confusion, Alopecia, Abdominal discomfort, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, Drug-induced liver injury, Fatigue, Exposure during pregnancy, General physical health deterioration, Glossodynia, Hepatic enzyme increased, Hand deformity, Hypersensitivity, Hypertension, Off label use, |
||||
CELECOXIB, CELECOXIB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, OXYCODONE, RAMIPRIL, PANTOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, CANDESARTAN, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, GOLIMUMAB, TRETINOIN, TOFACITINIB, VITAMIN C, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, ERGOCALCIFEROL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, |
||||
| 1046 | 24971478 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, LUTETIUM LU 177 DOTATATE, |
||||
| 1047 | 24971658 |
CA |
2 | |
Hospitalisation, Dysarthria, General physical health deterioration, Drug ineffective, |
||||
ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 1048 | 24972319 |
RU |
37 | 2 |
General physical health deterioration, Drug ineffective, Rheumatoid nodule, Vomiting, Musculoskeletal stiffness, Finger deformity, Nausea, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, |
||||
| 1049 | 24963166 |
US |
36 | 2 |
Ileostomy, Hyperhidrosis, Chills, Crohn^s disease, Fatigue, Asthenia, Decreased appetite, Arthralgia, Insomnia, General physical health deterioration, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1050 | 24963178 |
DE |
80 | 1 |
Sleep disorder, Device issue, Hallucination, Cognitive disorder, Poor quality sleep, Rapid eye movement sleep behaviour disorder, On and off phenomenon, Pneumonia aspiration, Urosepsis, Hiatus hernia, Gastrooesophageal reflux disease, Vitamin B6 deficiency, Folate deficiency, Axonal and demyelinating polyneuropathy, Normochromic normocytic anaemia, Nausea, Vomiting, Weight decreased, Device dislocation, Osteochondrosis, Atrioventricular block, Hypertension, Lumbar vertebral fracture, Fall, Feeding disorder, Hypoaesthesia, General physical health deterioration, Disorientation, Aggression, Nocturia, Constipation, Depressed mood, Psychomotor skills impaired, Asthenia, Diastolic dysfunction, Gait disturbance, Mobility decreased, Thrombocytopenia, Abdominal pain, Cough, Dysphagia, Intentional medical device removal by patient, Intentional device misuse, Device related thrombosis, Haematuria, Polyneuropathy, Cardiomegaly, Psychotic symptom, Bradykinesia, Decreased appetite, Hallucination, visual, Hallucination, auditory, Paranoia, Malaise, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, NALOXONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PREGABALIN, RISPERIDONE, THIAMINE HYDROCHLORIDE, FOLIC ACID, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, OXYCODONE, PANTOPRAZOLE, PYRIDOXINE HYDROCHLORIDE, |
||||
| 1051 | 24963319 |
US |
||
Leukodystrophy, General physical health deterioration, |
||||
BELIMUMAB, |
||||
| 1052 | 24963608 |
CA |
3 | 1 |
Seizure, Infection, Tremor, Poor sucking reflex, General physical health deterioration, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, GENTAMICIN, GENTAMICIN SULFATE, |
||||
| 1053 | 24963697 |
CA |
2 | |
Deep vein thrombosis, Pulmonary infarction, Pulmonary embolism, Dyspnoea, General physical health deterioration, Hypoxia, Therapeutic procedure, Peripheral swelling, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 1054 | 24963830 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1055 | 24963849 |
DE |
48 | 1 |
General physical health deterioration, Infection, |
||||
OCRELIZUMAB, OCRELIZUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, INTERFERON BETA-1A, |
||||
| 1056 | 24963880 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1057 | 24963899 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1058 | 24963982 |
US |
77 | 1 |
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1059 | 24964158 |
DE |
53 | 2 |
Increased upper airway secretion, Listless, COVID-19, Noninfective gingivitis, General physical health deterioration, Asthenia, Fatigue, Dizziness, Gait disturbance, |
||||
OCRELIZUMAB, ERGOCALCIFEROL, |
||||
| 1060 | 24964172 |
JP |
30 | 1 |
General physical health deterioration, Frequent bowel movements, Haematochezia, Diarrhoea, Pyrexia, White blood cell count increased, C-reactive protein increased, Blood albumin decreased, Blood cholinesterase decreased, |
||||
MESALAMINE, AZATHIOPRINE, |
||||
| 1061 | 24964600 |
US |
2 | |
General physical health deterioration, Kidney infection, Lung disorder, Illness, Cough, Malaise, Pyrexia, Hypersensitivity, Nausea, Drug tolerance decreased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, GABAPENTIN, THYROID, PORCINE, NINTEDANIB, OXYGEN, 0XYGEN, |
||||
| 1062 | 24964631 |
CA |
||
Hypoglycaemia, Fall, General physical health deterioration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 1063 | 24964676 |
DE |
67 | 1 |
Immune-mediated cholangitis, General physical health deterioration, Dizziness, Asthenia, Gait disturbance, |
||||
NIVOLUMAB, IPILIMUMAB, CARBOPLATIN, RAMIPRIL, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ISONIAZID, RIFAMPIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, |
||||
| 1064 | 24964687 |
US |
78 | 2 |
Diarrhoea, Constipation, General physical health deterioration, |
||||
LENALIDOMIDE, |
||||
| 1065 | 24965854 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 1066 | 24966208 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, APREMILAST, LEFLUNOMIDE, LORAZEPAM, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, CYANOCOBALAMIN, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ERENUMAB-AOOE, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LAMOTRIGINE, LANSOPRAZOLE, LISINOPRIL, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, POVIDONE-IODINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, SULFASALAZINE, FISH OIL, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, METHOTREXATE, METHOTREXATE SODIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ERENUMAB-AOOE, CALCIUM GLUCONATE, |
||||
| 1067 | 24966316 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1068 | 24966830 |
DE |
44 | |
Metastasis, General physical health deterioration, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 1069 | 24966831 |
DE |
2 | |
Blindness unilateral, Herpes zoster, General physical health deterioration, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 1070 | 24966906 |
RU |
2 | |
Hypercholesterolaemia, Eye disorder, Carotid artery disease, Platelet count increased, General physical health deterioration, |
||||
ANASTROZOLE, |
||||
| 1071 | 24966917 |
FR |
76 | 2 |
Cardiac failure, Pulmonary embolism, Dermatitis bullous, Diabetes mellitus inadequate control, General physical health deterioration, Dermatitis, Hypothalamic pituitary adrenal axis suppression, Dyspnoea, Oedema peripheral, Asthenia, Fall, Product use issue, Product use in unapproved indication, Off label use, Dysstasia, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, APIXABAN, APIXABAN, APIXABAN, APIXABAN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, |
||||
| 1072 | 24967008 |
DE |
||
Liver function test increased, Abdominal discomfort, Abdominal pain upper, Ocular icterus, Blood test abnormal, Skin odour abnormal, Gastrooesophageal reflux disease, General physical health deterioration, Muscular weakness, Hypophagia, Chromaturia, Faeces discoloured, Stress, Crying, Tachycardia, Pyrexia, |
||||
ELOSULFASE ALFA, |
||||
| 1073 | 24967026 |
CA |
26 | 1 |
SARS-CoV-2 test positive, Dry skin, Pruritus, Fatigue, Headache, Cough, Oropharyngeal pain, Haematochezia, Eczema, Off label use, General physical health deterioration, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB, |
||||
| 1074 | 24967329 |
NO |
68 | |
Fournier^s gangrene, Nausea, Vomiting, General physical health deterioration, Pyrexia, Sepsis, Perineal operation, |
||||
DAPAGLIFLOZIN, ATORVASTATIN CALCIUM, |
||||
| 1075 | 24957554 |
FR |
62 | 2 |
General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LOSARTAN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, MIRTAZAPINE, |
||||
| 1076 | 24957593 |
CA |
40 | 2 |
Abdominal pain upper, Dyspnoea, Fatigue, Inflammation, Injection site reaction, Off label use, Synovitis, Treatment failure, Arthralgia, Bursitis, Drug intolerance, Glossodynia, Systemic lupus erythematosus, Therapeutic product effect decreased, Wound, Alopecia, Asthenia, Blood cholesterol increased, General physical health deterioration, Mobility decreased, Wheezing, Arthropathy, Confusional state, Hypertension, Ill-defined disorder, Taste disorder, Therapeutic product effect incomplete, Type 2 diabetes mellitus, Weight increased, Wound infection, Folliculitis, Gastrooesophageal reflux disease, Hand deformity, Urticaria, C-reactive protein increased, Decreased appetite, Hepatic enzyme increased, Hypoaesthesia, Vomiting, Abdominal discomfort, Anti-cyclic citrullinated peptide antibody positive, Drug-induced liver injury, Gastrointestinal disorder, Joint swelling, Maternal exposure during pregnancy, |
||||
TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, USTEKINUMAB, VITAMIN C, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, HYDROCORTISONE, HYDROCORTISONE ACETATE, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, GOLIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, SARILUMAB, LAMOTRIGINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, RAMIPRIL, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RITUXIMAB, SULFASALAZINE, APREMILAST, DICLOFENAC, DICLOFENAC SODIUM, TOFACITINIB, RITUXIMAB, RITUXIMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 1077 | 24957702 |
CO |
75 | 1 |
General physical health deterioration, |
||||
VENETOCLAX, |
||||
| 1078 | 24957798 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1079 | 24957918 |
CA |
8 | 1 |
Asthma, Breath odour, Cough, Cyanosis, Dyspnoea, Fear of injection, Forced expiratory volume decreased, General physical health deterioration, Heart rate decreased, Malaise, Middle insomnia, Oral discomfort, Respiration abnormal, Weight increased, Wheezing, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, MONTELUKAST SODIUM, |
||||
| 1080 | 24958054 |
CA |
54 | 2 |
Arthritis, General physical health deterioration, Rheumatoid arthritis-associated interstitial lung disease, Weight decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 1081 | 24958170 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Asthenia, Arthralgia, Blepharospasm, Blood cholesterol increased, Blister, Bursitis, Breast cancer stage III, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Decreased appetite, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fibromyalgia, Fatigue, Folliculitis, Gastrooesophageal reflux disease, Glossodynia, General physical health deterioration, Hand deformity, Headache, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Impaired healing, Hypocholesterolaemia, Inflammation, Irritable bowel syndrome, Infusion related reaction, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver injury, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Obesity, Night sweats, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Vomiting, Urticaria, Weight increased, Wheezing, Wound, Contraindicated product administered, Maternal exposure during pregnancy, Exposure during pregnancy, Product quality issue, Wound infection, Helicobacter infection, Lower respiratory tract infection, |
||||
SARILUMAB, |
||||
| 1082 | 24958186 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1083 | 24958221 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1084 | 24958421 |
FI |
53 | 1 |
Asthenia, General physical health deterioration, Transient ischaemic attack, Overdose, |
||||
OLANZAPINE PAMOATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MELATONIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OLANZAPINE, |
||||
| 1085 | 24958487 |
US |
2 | |
Parkinson^s disease, Dementia, General physical health deterioration, Overdose, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1086 | 24958609 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1087 | 24958627 |
CA |
80 | 2 |
Blood pressure systolic increased, General physical health deterioration, Hernia, Pruritus, Urticaria, Weight decreased, Drug ineffective, Therapeutic response decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 1088 | 24958661 |
US |
1 | |
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1089 | 24958835 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1090 | 24958893 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1091 | 24959055 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1092 | 24959151 |
CA |
2 | |
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fibromyalgia, Fluid retention, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Pulmonary fibrosis, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
SARILUMAB, |
||||
| 1093 | 24959219 |
CA |
44 | 2 |
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Frequent bowel movements, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Porphyria acute, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, |
||||
INDOMETHACIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREDNISONE, PREDNISONE, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SECUKINUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, RITUXIMAB-ABBS, RITUXIMAB-ABBS, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, FISH OIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CALCIUM GLUCONATE, ERGOCALCIFEROL, QUETIAPINE FUMARATE, QUETIAPINE, LANSOPRAZOLE, |
||||
| 1094 | 24959361 |
US |
71 | 2 |
General physical health deterioration, Pain, Rheumatoid arthritis, |
||||
ABATACEPT, ABATACEPT, |
||||
| 1095 | 24959461 |
DE |
72 | 2 |
General physical health deterioration, Neoplasm progression, |
||||
LETROZOLE, PALBOCICLIB, |
||||
| 1096 | 24959499 |
JP |
15 | 1 |
Death, General physical health deterioration, Pain, Gastrointestinal disorder, Alpha 1 foetoprotein increased, |
||||
DABRAFENIB, DABRAFENIB, TRAMETINIB, TRAMETINIB, |
||||
| 1097 | 24959557 |
LT |
30 | 2 |
Maternal exposure during pregnancy, General physical health deterioration, Dyspnoea at rest, Respiratory failure, Drug ineffective, Premature delivery, |
||||
FUROSEMIDE, SPIRONOLACTONE, METOPROLOL TARTRATE, METOPROLOL, CEFAZOLIN SODIUM, CEFAZOLIN, METOPROLOL TARTRATE, METOPROLOL, FUROSEMIDE, CEFAZOLIN SODIUM, CEFAZOLIN, |
||||
| 1098 | 24959560 |
US |
40 | 2 |
Rheumatoid arthritis, Respiratory syncytial virus bronchitis, Arthralgia, General physical health deterioration, |
||||
ABATACEPT, ABATACEPT, |
||||
| 1099 | 24959649 |
US |
2 | |
Drug interaction, General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1100 | 24959738 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28